相关实验视频
Updated: Jan 13, 2026

08:28
Single-molecule Manipulation of G-quadruplexes by Magnetic Tweezers
Published on: September 19, 2017
8.5K
小分子c-Myc G-四重复结合剂的基于结构的药物设计
Jian Gao1,2, Chenxi Xu3,4, Renjie Hong3,4
1The First Affiliated Hospital of Anhui University of Science and Technology (Huainan First People's Hospital), Huainan, China. gaojian@aust.edu.cn.
Journal of computer-aided molecular design
|January 12, 2026
概括
研究人员确定了Y502-3888,这是一个与c-Myc G-quadruplex (G4) 结构结合的新型化合物. 这一发现为在癌症治疗中准"不可抗药"c-Myc瘤基因提供了新的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 这种c-Myc瘤基因在癌症发育中起着关键作用.
- c-Myc的蛋白质结构缺乏可使用药物的口袋,这对直接治疗向构成了挑战.
- 该c-Myc促进体可以形成G-四重复 (G4) 结构,提供间接抑制策略.
研究的目的:
- 为了识别与c-Myc G-quadruplex (G4) 结构结合的小分子.
- 评估这些分子作为癌症治疗剂的潜力,特别是多发性骨髓瘤.
- 建立开发针对c-Myc G4的新型抗癌药物的基础.
主要方法:
- 使用c-Myc G4晶体结构对ChemDiv化合物库进行基于结构的虚拟选.
- 在体外测试以评估候选化合物的生物活性.
- 对Y502-3888对c-Myc mRNA和蛋白质表达水平的影响的评估.
主要成果:
- 化合物Y502-3888被确定为c-Myc G4结构的结合剂.
- Y502-3888有效地降低了mRNA和蛋白质水平上的c-Myc表达.
- 在体外初步测定证实了Y502-3888.8.的生物活性.
结论:
- Y502-3888显示出作为治疗多发性骨髓瘤 (MM) 的c-Myc G4结合剂的潜力.
- 这项研究为开发针对c-Myc G4结构的新抗癌药物提供了基础.
- 这些发现突出了针对以前"不可抗药"的c-Myc瘤基因的有希望的新途径.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Cooperative Binding of Transcription Regulators
7.1K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.1K

